Contraceptive Hormone and Reward Measurement (CHARM Study)

PHASE4RecruitingINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Oral Hormonal Contraceptive UseNeural ActivityMoodHedonic Function
Interventions
DRUG

Levonorgestrel/ethinyl estradiol

Levonorgestrel 0.15mg/ethinyl estradiol 0.03mg

DRUG

Placebo

Placebo comparator

Trial Locations (1)

80045

RECRUITING

University of Colorado Denver Anschutz Medical Campus, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER